Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV

By afschroeder • August 22, 2025

Erlandson KM, Orkaby AR, Umbleja T, Ribaudo HJ, Brown TT, Zanni MV, Diggs MR, Chu SM, Fitch KV, Fichtenbaum CJ, Malvestutto C, Aberg JA, Bloomfield GS, Currier JS, Tashima KT, de Lacerda MVG, Heath SL, Lu MT, Landay A, Kuchel GA, Douglas PS, Grinspoon SK. Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV. JACC Adv. 2025 Aug 20;4(9):102077. doi: 10.1016/j.jacadv.2025.102077. Epub ahead of print. PMID: 40839903.

Tags: Frailty, HIV, Infectious Diseases, Major adverse cardiovascular event, Publications, statin

Implementation of a One Health Surveillance System in the Democratic Republic of the Congo

Kinzie PR, Lombe B, Merritt S, Halbrook M, Vakaniaki EH, Mukadi P, L'k'ye AM, Mona J, Kanonge D, Mfwangkang M, Witte D, Melofchik C, Muyembe-Tamfum[...]

Early antiretroviral therapy and long-term cancer risk in HIV: 9-year outcomes from the START randomized trial

Ramaswami R, Nordwall JA, Gilbert D, Kitchell E, Timiryasova A, Mitsuyasu R, Phillips AN, Lundgren J, Grabar S. Early antiretroviral therapy and long-term cancer risk[...]

Kidney abnormalities in young people living with HIV on dolutegravir-based regimens in Kampala, Uganda

Nasuuna EM, Hoffman R, Kalyesubula R, Chikwari CD, Weiss HA. Kidney abnormalities in young people living with HIV on dolutegravir-based regimens in Kampala, Uganda. AIDS[...]